Single-Chain Variable Fragment-Based Bispecific Antibodies: Hitting Two Targets with One Sophisticated Arrow

Despite the success of monoclonal antibodies (mAbs) to treat some disorders, the monospecific molecular entity of mAbs as well as the presence of multiple factors and pathways involved in the pathogenesis of disorders, such as various malignancies, infectious diseases, and autoimmune disorders, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahamadi-Fesharaki, Raoufeh, Fateh, Abolfazl, Vaziri, Farzam, Solgi, Ghasem, Siadat, Seyed Davar, Mahboudi, Fereidoun, Rahimi-Jamnani, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463744/
https://www.ncbi.nlm.nih.gov/pubmed/31011631
http://dx.doi.org/10.1016/j.omto.2019.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463744/
https://www.ncbi.nlm.nih.gov/pubmed/31011631
http://dx.doi.org/10.1016/j.omto.2019.02.004

Ejemplares similares